Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors.It is founded in 2019 and is based in Martinsried, Bavaria.

Biotechnology

Eisbach Bio GmbH

Eisbach Bio GmbH's headquarters in Munich, Germany

Adrian Schomburg

Daniel Gau

Jonathan Iorio

Andreas Ladurner

This department focuses on overseeing clinical trials and managing data related to clinical research.

Clinical Operations

This department focuses on the research and development of new pharmaceuticals and medicinal compounds.

Drug Development

This department manages financial operations and oversees business alliances to drive organizational growth.

Finance and Partnerships

This department focuses on the research and development of drug candidates before they enter clinical trials.

Preclinical Development

This department focuses on scientific research and development initiatives to innovate and enhance products and solutions.

Eisbach Bio GmbH

Org chart

Teams

Clinical Operations

Drug Development

Finance and Partnerships

Preclinical Development

Research and Development

Offices

Eisbach Bio GmbH

Org chart

Teams

Clinical Operations

Drug Development

Finance and Partnerships

Preclinical Development

Research and Development

Offices

Related companies